No Data
Shanghai Sanyou Medical Co., Ltd's (SHSE:688085) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Shanghai Sanyou Medical Co., Ltd (688085.SH): is actively exploring the application scenarios of AI intelligence in the innovation of orthopedic therapy vertical large models.
On March 12, Glonghui reported that Shanghai Sanyou Medical Co., Ltd (688085.SH) stated on the interactive platform that the company has not yet deployed DeepSeek. However, the company is actively exploring application scenarios of AI intelligence in the innovation of orthopedic therapies by integrating the Spring Breeze Ortho Surgery Robot and the Shumuyuan Ultrasonic Bone Knife and other related intelligent surgical technologies.
Sanyou Healthcare: 2024 Annual Results Express Announcement
2024 Annual Results Express Announcement
Shanghai Sanyou Medical Co., Ltd (688085.SH): The net income for 2024 is 11.2996 million yuan, a decrease of 88.18% year-on-year.
On February 27, Gelonghui reported that Shanghai Sanyou Medical Co., Ltd (688085.SH) announced its performance report for 2024. During the reporting period, the company achieved a total operating revenue of 452.645 million yuan, a decrease of 1.68% year-on-year; research and development expenses amounted to 84.1175 million yuan, an increase of 28.98% year-on-year; the proportion of research and development investment was 18.58%, an increase of 4.41 percentage points compared to the same period last year; net income attributable to the parent company was 11.2996 million yuan, a decrease of 88.18% year-on-year; net income attributable to the parent company, after deducting non-recurring gains and losses, was -3.9982 million yuan.
Shanghai Sanyou Medical Completes Share Issuance for Asset Acquisition
There Are Reasons To Feel Uneasy About Shanghai Sanyou Medical's (SHSE:688085) Returns On Capital
